Lentechs is developing a patented line of soft, suspended bifocal contact lenses that utilize the eye's anatomy to provide clear vision at all distances. This technology addresses the needs of the 120 million U.S. patients with presbyopia who prefer contact lenses over glasses but often experience inadequate visual correction with existing options.
Funding
$12.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Approximately 120 million people in the U.S. and 2 billion worldwide have presbyopia, a condition where the eyes gradually lose the ability to clearly see close objects. Many presbyopia patients wear spectacles but would prefer contact lenses; however, current contact lens technologies often fail to provide satisfactory vision correction at all distances.
Solution
Lentechs is developing a novel line of soft, suspended bifocal contact lenses designed to provide clear vision at all distances for individuals with presbyopia. These lenses are designed to utilize the eye’s anatomy, differing from traditional lenses that conform to it. The Lentechs lens is suspended behind the upper eyelid, allowing for natural translational eye movement behind the rotationally stable, centered contact lens. This design enables wearers to access the specific prescription needed for near, intermediate, and far vision correction.
Target Audience
The primary target audience includes the large population of individuals with presbyopia who prefer contact lenses over spectacles for vision correction.
Features
- Suspended lens design that allows free translational eye movement behind the lens.
- Rotationally stable, centered contact lens.
- Utilizes the eye's anatomy to provide distance-specific prescription access.
- Soft contact lens material for enhanced comfort.
- Lenticular-like curve for vision correction.
- Enhanced tear exchange for improved eye health.
- Protected by multiple U.S. and global patents.